An assessment of the reporting quality of randomised controlled trials relating to anti-arrhythmic agents (2002-2011)

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 1393-1396

  Camm, Christian Fielder ^a   Chen, Yang ^a   Sunderland, Nicholas ^a   Nagendran, Myura ^a   Maruthappu, Mahiben ^a   Camm, A John ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Anti arrhythmics; CONSORT; Randomised controlled trials; Trial reporting

Indexed keywords

ANTIARRHYTHMIC AGENT;

ARTICLE; BIBLIOGRAPHIC DATABASE; CORRELATION ANALYSIS; HEART ARRHYTHMIA; HUMAN; INFORMATION PROCESSING; JOURNAL IMPACT FACTOR; MEDICAL LITERATURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW;

ANTI-ARRHYTHMICS; CONSORT; RANDOMISED CONTROLLED TRIALS; TRIAL REPORTING;

ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; HUMANS; JOURNAL IMPACT FACTOR; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84885321870     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.12.020     Document Type: Article

References (41)

1. Jüni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001;323(7303):42-6.
2. Chan AW, Altman DG. Epidemiology and reporting of randomised trials published in PubMed journals. Lancet 2005;365(9465):1159-62.
3. Glasziou P, Meats E, Heneghan C, Shepperd S. What is missing from descriptions of treatment in trials and reviews? BMJ 2008;336(7659):1472-4.
4. Dwan K, Altman DG, Arnaiz JA, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One 2008;3(8):e3081.
5. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996;276(8):637-9.
6. Schulz KF, Altman DG, Moher D. CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. BMJ 2010;340:c332.
7. Moher D, Schulz KF, Altman DG. CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trails. Ann Intern Med 2001;134(8):657-62.
8. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12.
9. Moher D, Pham B, Jones A, et al. Does the quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998;352(9128):609-13.
10. Thornley B, Adams C. Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ 1998;317(7167):1181-4.
11. Dickinson K, Bunn F, Wentz R, Edwards P, Roberts I. Size and quality of randomised controlled trials in head injury: review of published studies. BMJ 2000;320(7245):1308-11.
12. Montori VM, Wang YG, Alonso-Coello P, Bhagra S. Systematic evaluation of the quality of randomized controlled trials in diabetes. Diabetes Care 2006;29(8):1833-8.
13. Huwiler-Müntener K, Juni P, Junker C, Egger M. Quality of reporting of randomized trials as a measure of methodologic quality. JAMA 2002;287(21):2801-4.
14. Kusumoto FM, Kusumoto H. Publication trends in cardiovascular research over the last 20 years: implications for funding and cost of healthcare. J AmColl Cardiol 2012;59:E1837.
15. Ganjehei L, Massumi A, Nazeri A, Razavi M. Pharmacologic management of arrhythmias. Tex Heart Inst J 2011;38(4):344-9.
16. Camm AJ, Camm CF, Savelieva I. Medical treatment of atrial fibrillation. J Cardiovasc Med (Hagerstown) 2012;13(2):97-107.
17. Wolbrette D, Naccarelli G, Curtis A, Lehmann M, Kadish A. Gender differences in arrhythmias. Clin Cardiol 2002;25(2):49-56.
18. Levy D, Anderson KM, Savage DD, Balkus SA, Kannel WB, Castelli WP. Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987;60(7):560-5.
19. Hernández AV, Boersma E, Murray GD, Habbema JD, Steyerberg EW. Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading? Am Heart J 2006;151(2):257-64.
20. Agha R, Cooper D, Muir G. The reporting quality of randomised controlled trials in surgery: a systematic review. Int J Surg 2007;5(6):413-22.
21. Sadr-Azodi O, Andrén-Sandberg A. The quality of randomized clinical trials in the field of surgery: studies on laparoscopic versus open appendectomy as an example. Dig Surg 2009;26(5):351-7.
22. Ethgen M, Boutron L, Steg PG, Roy C, Ravaud P. Quality of reporting internal and external validity data from randomized controlled trials evaluating stents for percutaneous coronary intervention. BMC Med Res Methodol 2009;9(9):24.
23. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0In: Higgins JPT, Green S, editors. 2011 [online. Available from: http://www.cochrane.org/training/cochrane-handbook. Accessed: 18 August 2012].
24. Mucklow JC. Reporting drug safety in clinical trials: getting the emphasis right. Lancet 2001;357(9266):1384.
25. Ioannidis JPA, Evans SJ, Goøtzsche PC, et al. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med 2004;141(10):781-8.
26. Figg WD, Dunn L, Liewehr DJ, et al. Scientific collaboration results in higher citation rates of published articles. Pharmacotherapy 2006;26(6):759-67.
27. Willis DL, Bahler CD, Neuberger MM, Dahm P. Predictors of citations in the urological literature. BJU Int 2011;107(12):1876-80.
28. ISI Web of Knowledge. 2012 [online]. Available from http://wok.mimas.ac. uk/. [Accessed: 18 August 2012].
29. Hopewell S, Dutton S, Yu LM, Chan AW, Altman DG. The quality of reports of randomized trials in 2000 and 2006: comparative study of articles indexed in PubMed. BMJ 2010;340:c723.
30. Fung AE, Palanki R, Bakri SJ, Depperschmidt E, Gibson A. Applying the CONOSRT and STROBE statements to evaluate the reporting quality of neovascular age-related macular degeneration studies. Ophthalmology 2009;116(2):286-96.
31. Péron J, Pond GR, Gan HK, et al. Quality of Reporting of modern randomized controlled trials in medical oncology: a systematic review. J Natl Cancer Inst 2012;104(13):982-9.
32. Wilber DJ, Pappone C, Neuzil P, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation; a randomized controlled trial. JAMA 2010;303(4):333-40.
33. Chew M, Villanueva EV, Van der Weyden MB. Life and times of the impact factor: retrospective analysis of trends for seven medical journals (1994-2005) and their editor's views. J R Soc Med 2007;100(3):142-50.
34. Sinha S, Sinha S, Ashby E, Jayaram R, Grocott MP. Quality of reporting in randomized trials published in high-quality surgical journals. J AmColl Surg 2009;209(5): 565-71 [e1].
35. Hist A, Altman DG. Are peer reviewers encouraged to use reporting guidelines? A survey of 116 health research journals. PLoS One 2012;7(4):e35621.
36. Li XQ, Tao KM, Zhou QH, et al. Endorsement of the CONSORT statement by high-impact medical journals in China: a survey of instructions for authors and published papers. PLoS One 2012;7(2):e30683.
37. Hopewell S, Altman DG, Moher D, Schulz KF. Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'. Trials 2008;9:20.
38. Plint AC, Moher D, Morrison A, et al. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust 2006;185(5):263-7.
39. Furler J, Magin P, Pirotta M, van Driel M. Participant demographics reported in "Table 1" of randomized controlled trials: a case of "inverse evidence"? Int J Equity Health 2012;11(1):14.
40. Breau RH, Gaboury I, Scales Jr CD, Fesperman SF, Watterson JD, Dahm P. Reporting of harm in randomized controlled trials published in the urological literature. J Urol 2010;183(5):1693-7.
41. Montgomery S. Of Towers, walls, and fields: perspectives on language in science. Science 2004;303(5662):1333-5.